VANCOUVER, BC — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to announce that the last patient… Read More
SINGAPORE — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it… Read More
Study will use delta-9 dominant THCV manufactured by InMed’s subsidiary BayMedica Assesses key health outcomes for energy, focus, appetite and weight/BMI Provides valuable evidence-based data on cannabinoids for consumers, brands… Read More
GlaxoSmithKline plc (LSE/NYSE: GSK) has today announced that Dr Vishal Sikka, founder and CEO of Vianai Systems, will join the Board of the Company as a Non-Executive Director. He will… Read More
Medical devices undergoing testing at St. Paul’s Hospital with U.S. trials to follow By Tyler Orton September often means Labour Day barbecues, back-to-school shopping for the kids and final visits… Read More
